- Home
- FNA vs IRS Comparison
FNA vs IRS Comparison
Compare FNA & IRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNA
- IRS
- Stock Information
- Founded
- FNA 2010
- IRS 1943
- Country
- FNA United States
- IRS Argentina
- Employees
- FNA N/A
- IRS N/A
- Industry
- FNA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- IRS Homebuilding
- Sector
- FNA Health Care
- IRS Real Estate
- Exchange
- FNA Nasdaq
- IRS Nasdaq
- Market Cap
- FNA 910.9M
- IRS N/A
- IPO Year
- FNA 2021
- IRS 1994
- Fundamental
- Price
- FNA $13.05
- IRS $12.89
- Analyst Decision
- FNA Buy
- IRS Strong Buy
- Analyst Count
- FNA 7
- IRS 1
- Target Price
- FNA $15.20
- IRS $12.62
- AVG Volume (30 Days)
- FNA 1.5M
- IRS 117.3K
- Earning Date
- FNA 03-06-2025
- IRS 05-06-2025
- Dividend Yield
- FNA N/A
- IRS 12.34%
- EPS Growth
- FNA N/A
- IRS N/A
- EPS
- FNA N/A
- IRS N/A
- Revenue
- FNA $256,182,000.00
- IRS $325,094,048.00
- Revenue This Year
- FNA $14.88
- IRS N/A
- Revenue Next Year
- FNA $13.92
- IRS N/A
- P/E Ratio
- FNA N/A
- IRS N/A
- Revenue Growth
- FNA 18.39
- IRS N/A
- 52 Week Low
- FNA $4.65
- IRS $8.21
- 52 Week High
- FNA $13.13
- IRS $17.67
- Technical
- Relative Strength Index (RSI)
- FNA 65.45
- IRS 44.69
- Support Level
- FNA $13.01
- IRS $13.22
- Resistance Level
- FNA $13.05
- IRS $13.94
- Average True Range (ATR)
- FNA 0.03
- IRS 0.70
- MACD
- FNA -0.03
- IRS 0.04
- Stochastic Oscillator
- FNA 52.50
- IRS 35.71
About FNA Paragon 28 Inc.
Paragon 28 Inc is a medical devices company that develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products include plates and plating systems, screws, staples, and nails aimed to address all major foot and ankle procedures including ankle, Charcot, fracture fixation, hallux valgus, hammertoe, and flat foot. The company's suite of surgical solutions comprises nearly 80 product systems to help fit the specific needs of each patient and procedure. Geographically the company generates the majority of its revenue from the United States.